Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)

Mise à jour : Il y a 4 ans
Référence : NCT02149017

Femme et Homme

Extrait

To evaluate pharmacokinetics, safety and efficacy of SNUBH-NM-333(18F), a new diagnostic radiopharmaceutical for PET imaging of amyloid plaques, in Alzheimer's disease patients and healthy volunteers.


Critère d'inclusion

  • Alzheimer Disease

Liens